We are monitoring the impact of COVID-19 on Asia Pacific Mycoplasma Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3522
Share on
Share on

Asia Pacific Mycoplasma Testing Market Research Report - Segmented By Product, Technique, Application, End-User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecast To 2026

Pulished: April, 2021
ID: 3522
Pages: 138

APAC Mycoplasma Testing Market Size & Growth (2021 to 2026):

The Size of the Mycoplasma Testing Market in the Asia Pacific is valued at USD 137.85 Million in 2021 and is expected to be growing at a CAGR of 16.7%, to reach USD 298.37 Million by 2026 during the forecast period 2021 to 2026.

DRIVERS

Mycoplasma spreads easily through droplets through cell culture and can persist in a dry form for months. Mycoplasma infection is complex to see under a microscope and requires specific tests to be detected. Infection can have an acute impact on experimental work depending on the species present. These will lead to cross contamination of cell cultures and drive the growth rate for mycoplasma testing.

Major bio pharmaceutical companies operating in the market are making various strategic investments, such as launching innovative products, advancing research and development, and technological innovations, which are gaining popularity in the mycoplasma testing market and expand the consumer base to survive in a competitive business environment in APAC regions.

RESTRAINTS

Lack of trained / skilled molecular biologists is expected to slow the market growth during the forecast period. Mycoplasma testing requires certain specialized skills seen in professional from life sciences, pharmaceuticals, electronics and software industries. The lack of trained personnel capable of conducting molecular biology experiments and interpreting the results is a major limitation of testing and containment of COVID-19 in developing countries.

OPPORTUNITIES

The growing incidences of mycoplasma pneumonia cross infection in many COVID-19 patients is expected to drive the market for mycoplasma testing during the forecast period. The presence of M. pneumonia cross infection increases the necessity to get the patients tested for COVID-19, increasing the demand for routine diagnostic tests for respiratory pathogens such as M. pneumonia. Co-infections in COVID-19 cases have a significant likelihood of being caused by Mycoplasma pneumoniae.

CHALLENGES

The high degree of consolidation is a significant barrier to entry for new entrants, which in turn is expected to restrict investment and therefore slow the growth potential of this market.

This research report on the Asia Pacific Mycoplasma Testing Market has been segmented and sub-segmented into the following categories

By Product:

  • Kits & Reagents
  • Instruments
  • Services

By Technique:

  • PCR
  • ELSA
  • Direct Assays
  • Indirect Assays
  • Microbial Culture Techniques
  • Enzymatic Methods
  • DNA Staining

By Application:

  • Cell Line Testing
  • Virus Testing
  • End-Of-Production Cell Testing
  • Others

By End-User:

  • Pharmaceutical Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Cell Banks

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

REGIONAL ANALYSIS

China accounted for the majority of the APAC mycoplasma testing market, and China will continue to be one of the fastest growing countries in this group of regional markets. Led by countries such as Australia, India and South Korea, the Asia-Pacific market is expected to reach US $ 196.9 million in the upcoming year.

China, the world's second-largest economy, is expected to reach a projected market size of US $ 296.3 million by 2027, with a CAGR of 15% over the analysis period from 2021 to 2026. Others Notable geographic market includes Japan reaching forecast growth of 7.6% and 9.8% over the period 2021-2026.

Much of this regional market growth can be attributed mainly to the development of the biotechnology and pharmaceutical industries, the high rate of adoption of new technologies and the large number of life science research studies conducted in this region along with regulatory policies adopted by health organizations to improve the quality of biosafety in countries such as China and India.

M. pneumoniae co-infection ranged from 1.2% to 40.9% depending on the population and diagnostic tests used, and the combined prevalence of M. pneumoniae co-infection among COVID-19 patients has been reported to 17.6%.These data suggest the healthy growth of mycoplasma testing in the APAC in the forecasted period 2021-2027.

Top Companies dominating the Asia Pacific Mycoplasma Testing Market Profiled in the Report are PromoCell GmbH, Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Lonza Group Ltd., Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, WuXi AppTec.,

1.Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemiology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Product

        5.1.1 Introduction           

        5.1.2 Kits & Reagent       

        5.1.3 Instruments           

        5.1.4 Services    

        5.1.5  Y-o-Y Growth Analysis, By Product              

        5.1.6  Market Attractiveness Analysis, By Product            

        5.1.7  Market Share Analysis, By  Product             

                5.2 Technique                   

        5.2.1 Introduction           

        5.2.2 PCR            

        5.2.3 ELSA           

        5.2.4 Direct Assays          

        5.2.5 Indirect Assays      

        5.2.6 Microbial culture techniques           

        5.2.7 Enzymatic Methods            

        5.2.8 DNA Staining          

        5.2.9 Y-o-Y Growth Analysis, By Technique          

        5.2.10 Market Attractiveness Analysis, By Technique      

        5.2.11 Market Share Analysis, By Technique       

                5.3 Application                 

        5.3.1 Introduction           

        5.3.2 Cell Line Testing    

        5.3.3 Virus Testing          

        5.3.4 End-Of-Production Cell Testing      

        5.3.5 Other Applications               

        5.3.6 Y-o-Y Growth Analysis, By Application         

        5.3.7  Market Attractiveness Analysis, By Application      

        5.3.8  Market Share Analysis, By Application       

                5.4 End-User                      

        5.4.1 Introduction           

        5.4.2 Pharmaceutical Companies              

        5.4.3 Contract Research Organizations   

        5.4.4 Academic Research Institutes         

        5.4.5 Cell Banks

        5.4.6 Y-o-Y Growth Analysis, By End User             

        5.4.7 Market Attractiveness Analysis, By End User           

        5.4.8 Market Share Analysis, By End User             

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Product

                        6.1.3.3 By Technique

                        6.1.3.4 By Application

                        6.1.3.5 By End User

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Product

                        6.1.4.3 By Technique

                        6.1.4.4 By Application

                        6.1.4.5 By End User

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Product

                        6.1.5.3 By Technique

                        6.1.5.4 By Application

                        6.1.5.5 By End User

                6.2 China     

                6.3 India      

                6.4 Japan    

                6.5 South Korea       

                6.6 Australia                      

7.Strategic Analysis                

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                 

                8.1 Thermo Fisher Scientific Inc.       

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Minerva Biolabs GmbH  

                8.3 Charles River Laboratories International

                8.4 Gibraltar Laboratories    

                8.5 Sartorius AG       

                8.6 Lonza Group Ltd.                      

                8.7 Merck KGaA       

                8.8 Roche Diagnostics                    

                8.9 SGS S.A.                       

                8.10 American Type Culture Collection                  

                8.11 InvivoGen                 

                8.12 PromoCell GmbH                   

                8.13 Biological Industries Israel Beit Haemek Ltd.      

                8.14 WuXi AppTec   

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables                

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Mycoplasma Testing Market By Product, From 2021 to 2026 ( USD Billion )
  2. Asia Pacific Kits & Reagent Market By Region, From 2021 to 2026 ( USD Billion )
  3. Asia Pacific Instruments      Market By Region, From 2021 to 2026 ( USD Billion )
  4. Asia Pacific Services  Market By Region, From 2021 to 2026 ( USD Billion )
  5. Asia Pacific Mycoplasma Testing Market By Technique, From 2021 to 2026 ( USD Billion )
  6. Asia Pacific PCR  Market By Region, From 2021 to 2026 ( USD Billion )
  7. Asia Pacific ELSA   Market By Region, From 2021 to 2026 ( USD Billion )
  8. Asia Pacific Direct Assays Market By Region, From 2021 to 2026 ( USD Billion )
  9. Asia Pacific Indirect Assays Market By Region, From 2021 to 2026 ( USD Billion )
  10. Asia Pacific Microbial culture techniques Market By Region, From 2021 to 2026 ( USD Billion )
  11. Asia Pacific Enzymatic Methods Market By Region, From 2021 to 2026 ( USD Billion )
  12. Asia Pacific DNA Staining Market By Region, From 2021 to 2026 ( USD Billion )
  13. Asia Pacific Mycoplasma Testing Market By Application, From 2021 to 2026 ( USD Billion )
  14. Asia Pacific Cell Line Testing Market By Region, From 2021 to 2026 ( USD Billion )
  15. Asia Pacific Virus Testing Market By Region, From 2021 to 2026 ( USD Billion )
  16. Asia Pacific Cell Testing Market By Region, From 2021 to 2026 ( USD Billion )
  17. Asia Pacific Mycoplasma Testing Market By  End User, From 2021 to 2026 ( USD Billion )
  18. Asia Pacific Pharmaceutical Companies Market By Region, From 2021 to 2026 ( USD Billion )
  19. Asia Pacific Contract Research Organizations  Market By Region, From 2021 to 2026 ( USD Billion )
  20. Asia Pacific Academic Research Institutes Market By Region, From 2021 to 2026 ( USD Billion )
  21. Asia Pacific Cell Banks Market By Region, From 2021 to 2026 ( USD Billion )
  22. Japan Mycoplasma Testing Market By Product, From 2021 to 2026 ( USD Billion )
  23. Japan Mycoplasma Testing Market By Technique, From 2021 to 2026 ( USD Billion )
  24. Japan Mycoplasma Testing Market By Application, From 2021 to 2026 ( USD Billion )
  25. Japan Mycoplasma Testing Market By  End User, From 2021 to 2026 ( USD Billion )
  26. China Mycoplasma Testing Market By Product, From 2021 to 2026 ( USD Billion )
  27. China Mycoplasma Testing Market By Technique, From 2021 to 2026 ( USD Billion )
  28. China Mycoplasma Testing Market By Application, From 2021 to 2026 ( USD Billion )
  29. China Mycoplasma Testing Market By  End User, From 2021 to 2026 ( USD Billion )
  30. India Mycoplasma Testing Market By Product, From 2021 to 2026 ( USD Billion )
  31. India Mycoplasma Testing Market By Technique, From 2021 to 2026 ( USD Billion )
  32. India Mycoplasma Testing Market By Application, From 2021 to 2026 ( USD Billion )
  33. India Mycoplasma Testing Market By  End User, From 2021 to 2026 ( USD Billion )
  34. Australia Mycoplasma Testing Market By Product, From 2021 to 2026 ( USD Billion )
  35. Australia Mycoplasma Testing Market By Technique, From 2021 to 2026 ( USD Billion )
  36. Australia Mycoplasma Testing Market By Application, From 2021 to 2026 ( USD Billion )
  37. Australia Mycoplasma Testing Market By  End User, From 2021 to 2026 ( USD Billion )
  38. South Korea Mycoplasma Testing Market By Product, From 2021 to 2026 ( USD Billion )
  39. South Korea Mycoplasma Testing Market By Technique, From 2021 to 2026 ( USD Billion )
  40. South Korea Mycoplasma Testing Market By Application, From 2021 to 2026 ( USD Billion )
  41. South Korea Mycoplasma Testing Market By  End User, From 2021 to 2026 ( USD Billion )
  42. Asia Pacific Mycoplasma Testing  Market By Kits & Reagent, From 2021 to 2026 ( USD Million )
  43. Asia Pacific PCR Assays Market By Region, From 2021 to 2026 ( USD Million )
  44. Asia Pacific Nucleic Acid Detection Kits Market By Region, From 2021 to 2026 ( USD Million )
  45. Asia Pacific Elimination Kits & Reagents Market By Region, From 2021 to 2026 ( USD Million )
  46. Asia Pacific Stains Market By Region, From 2021 to 2026 ( USD Million )
  47. Asia Pacific Standards & Controls Market By Region, From 2021 to 2026 ( USD Million )
  48. Asia Pacific Other Kits & Reagents Market By Region, From 2021 to 2026 ( USD Million )
  49. Japan Mycoplasma Testing  Market By Kits & Reagent, From 2021 to 2026 ( USD Million )
  50. China Mycoplasma Testing  Market By Kits & Reagent, From 2021 to 2026 ( USD Million )
  51. India Mycoplasma Testing  Market By Kits & Reagent, From 2021 to 2026 ( USD Million )
  52. Australia Mycoplasma Testing  Market By Kits & Reagent, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample